Seeq and Cognizant Collaborate on Industrial AI for Drug Manufacturing
Oct 08, 2026
Partnerships
QuVa Pharma Secures National Drug Diversion Software Agreement with Premier
May 5, 2026
QuVa Pharma has been awarded a national group purchasing agreement with Premier, Inc. for its Drug Diversion Software Solutions, effective May 1, 2026. The deal enables Premier members to access pre-negotiated pricing and terms for QuVa's BrightStream platform, which supports controlled substance oversight and compliance.
QuVa Pharma has been awarded a national group purchasing agreement with Premier, Inc. for its Drug Diversion Software Solutions, announced in a press release. The agreement took effect on May 1, 2026, and allows Premier members to access special pricing and terms negotiated by Premier.
The partnership expands QuVa's relationship with Premier through its BrightStream platform, which uses analytics to help health systems monitor and manage diversion risk. The software provides visibility into controlled substance activity, supports investigations, and generates documentation for regulatory compliance.
According to QuVa, BrightStream also offers reporting, benchmarking, and workflow management tools that unify pharmacy, nursing, and compliance operations. The platform aims to replace manual processes with standardized oversight across hospital systems.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Oct 16 McGraw Hill Adds AI Study Tools to Connect Oct 16 RapidCanvas Raises $29 Million to Expand Enterprise AI Platform Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 ALTOUR Unveils AI Platform for Corporate Travel Decisions Oct 16 BOC Group Adds AI Assistant to ADOIT 21More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
.png)
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Suvoda Updates Clinical Trial Platform With AI and Unified Access
Sep 30, 2026
Healthcare
INmune Bio and QCi Apply Quantum Computing to XPro Research
Oct 14, 2026
Life Sciences
Veeva to Showcase Falcon and Vault AI at Boston Summit
Oct 08, 2026
Biotech
Amgen Selects Veeva Vault CRM for Global Deployment
Sep 16, 2026
Life Sciences
AbbVie Partners With Valkai on AI Tools for Clinical Development
Sep 29, 2026
Biotech
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.